5'-Chloro-5'-deoxy-(±)-ENBA, a Potent and Selective Adenosine A1 Receptor Agonist, Alleviates Neuropathic Pain in Mice Through Functional Glial and Microglial Changes without Affecting Motor or Cardiovascular Functions

doi:10.3390/molecules171213712

Paper

5'-Chloro-5'-deoxy-(±)-ENBA, a Potent and Selective Adenosine A1 Receptor Agonist, Alleviates Neuropathic Pain in Mice Through Functional Glial and Microglial Changes without Affecting Motor or Cardiovascular Functions

Published Nov 22, 2012 · L. Luongo, R. Petrelli, L. Gatta

Molecules

Q1 SJR score

53

Citations

2

Influential Citations

Open Access PDF Full text Semantic Scholar

Abstract

This study was undertaken in order to investigate the effect of chronic treatment with 5′-chloro-5′-deoxy-(±)-ENBA, a potent and highly selective agonist of human adenosine A1 receptor, on thermal hyperalgesia and mechanical allodynia in a mouse model of neuropathic pain, the Spared Nerve Injury (SNI) of the sciatic nerve. Chronic systemic administration of 5′-chloro-5′-deoxy-(±)-ENBA (0.5 mg/kg, i.p.) reduced both mechanical allodynia and thermal hyperalgesia 3 and 7 days post-SNI, in a way prevented by DPCPX (3 mg/kg, i.p.), a selective A1 adenosine receptor antagonist, without exerting any significant change on the motor coordination or arterial blood pressure. In addition, a single intraperitoneal injection of 5′-chloro-5′-deoxy-(±)-ENBA (0.5 mg/kg, i.p.) 7 days post-SNI also reduced both symptoms for at least two hours. SNI was associated with spinal changes in microglial activation ipsilaterally to the nerve injury. Activated, hypertrophic microglia were significantly reduced by 5′-chloro-5′-deoxy-(±)-ENBA chronic treatment. Our results demonstrated an involvement of adenosine A1 receptor in the amplified nociceptive thresholds and in spinal glial and microglial changes occurred in neuropathic pain, without affecting motor coordination or blood pressure. Our data suggest a possible use of adenosine A1 receptor agonist in neuropathic pain symptoms.

Non-RCT

Animal Study

Study Snapshot

Chronic treatment with 5′-chloro-5′-deoxy-()-ENBA effectively reduces neuropathic pain symptoms in mice without affecting motor coordination or blood pressure.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Paper

5'-Chloro-5'-deoxy-(±)-ENBA, a Potent and Selective Adenosine A1 Receptor Agonist, Alleviates Neuropathic Pain in Mice Through Functional Glial and Microglial Changes without Affecting Motor or Cardiovascular Functions

Sign up to use Study Snapshot

References

Citations

Temporal changes of spinal microglia in murine models of neuropathic pain: a scoping review

Spinal microglia plays a crucial role in neuropathic pain progression, but more long-term studies are needed to better understand their dynamics and potential treatments.

2-Amino-5-arylethynyl-thiophen-3-yl-(phenyl)methanones as A1 Adenosine Receptor Positive Allosteric Modulators.

Fluoro-substituted 5-arylethynyl aminothiophenes show enhanced positive allosteric modulation activity at the human A1 adenosine receptor, offering potential drug candidates for engaging protective A1ARs.

Discovery and Structure–Activity Relationship Studies of Novel Adenosine A1 Receptor-Selective Agonists

Novel adenosine A1 receptor-selective agonists with halogen in the meta position on the aromatic ring show improved potency and selectivity compared to adenosine-based compounds.

MED1/BDNF/TrkB pathway is involved in thalamic hemorrhage-induced pain and depression by regulating microglia

PEALut effectively reduces mechanical hypersensitivity and prevents depressive-like behavior in thalamic hemorrhage-induced central post-stroke pain by reducing microglial activation.

Lack of efficacy of a partial adenosine A1 receptor agonist in neuropathic pain models in mice

Partial A1R agonist capadenoson did not show significant reduction in neuropathic pain behavior in mice, suggesting it is not a valuable treatment approach.

The role of adenosine A1 receptor in the peripheral tramadol's effect in the temporomandibular joint of rats.

Tramadol's peripheral analgesic and anti-inflammatory effects in the temporomandibular joint are mediated by adenosine A1 receptors, possibly expressed in macrophages in the joint tissue.

Adenosine Metabotropic Receptors in Chronic Pain Management

P1 adenosine receptors play a crucial role in chronic neuropathic pain, and targeting these receptors may provide a new treatment option for this condition.